Display options
Share it on

Cardiol Ther. 2015 Jun;4(1):39-46. doi: 10.1007/s40119-015-0040-4. Epub 2015 Jun 09.

Fractional Flow Reserve in Acute Myocardial Infarction: A Guide for Non-Culprit Lesions?.

Cardiology and therapy

Dmitriy S Sulimov, Mohamed Abdel-Wahab, Gert Richardt

Affiliations

  1. Heart Center, Segeberger Kliniken GmbH, Academic Teaching Hospital of the Universities of Kiel, Lübeck, and Hamburg, Bad Segeberg, Germany.

PMID: 26055262 PMCID: PMC4472643 DOI: 10.1007/s40119-015-0040-4

Abstract

In patients presenting with ST-segment elevation myocardial infarction (STEMI) and multi-vessel disease (MVD), the optimal therapy for non-culprit lesions is still a matter of debate. While guidelines discourage a concomitant treatment of infarct- and non-infarct-related arteries, recent studies document advantages of a complete (preventive) revascularization during primary percutaneous coronary intervention. Such an approach, however, may result in overtreatment, because angiography does not provide robust information about the functional severity of MVD. Fractional flow reserve (FFR) measurements can be a valuable guide for non-culprit lesions in acute myocardial infarction, but so far, only the reliability and safety of FFR measurements have been established in this setting. The clinical implications of an FFR-guided treatment strategy in STEMI patients with MVD are currently being tested in a large randomized trial.

References

  1. Rev Esp Cardiol. 2010 Jun;63(6):686-94 - PubMed
  2. J Am Coll Cardiol. 2013 Apr 2;61(13):1409-20 - PubMed
  3. J Am Coll Cardiol. 2012 Mar 20;59(12):1045-57 - PubMed
  4. Am J Cardiol. 2012 Apr 1;109(7):941-6 - PubMed
  5. JACC Cardiovasc Interv. 2011 Nov;4(11):1183-9 - PubMed
  6. JACC Cardiovasc Interv. 2010 Dec;3(12):1274-81 - PubMed
  7. Eur Heart J. 2007 Jul;28(14):1709-16 - PubMed
  8. J Am Coll Cardiol. 2011 Aug 9;58(7):704-11 - PubMed
  9. Am Heart J. 1991 Apr;121(4 Pt 1):1042-9 - PubMed
  10. J Am Coll Cardiol. 2015 Mar 17;65(10 ):963-72 - PubMed
  11. Am Heart J. 1992 Dec;124(6):1427-33 - PubMed
  12. J Am Coll Cardiol. 2002 Sep 4;40(5):911-6 - PubMed
  13. Eur Heart J. 2015 Apr 21;36(16):976-83 - PubMed
  14. Circ Cardiovasc Qual Outcomes. 2014 Nov;7(6):936-43 - PubMed
  15. Eur Heart J. 2010 Jul;31(14):1701-7 - PubMed
  16. Am Heart J. 2014 Jan;167(1):1-14.e2 - PubMed
  17. J Am Coll Cardiol. 2011 Aug 9;58(7):692-703 - PubMed
  18. Europace. 2012 Nov;14(11):1639-45 - PubMed
  19. J Am Coll Cardiol. 2012 Apr 10;59(15):1392-402 - PubMed
  20. J Am Coll Cardiol. 2007 May 29;49(21):2105-11 - PubMed
  21. N Engl J Med. 2013 Sep 19;369(12):1115-23 - PubMed
  22. Eur Heart J. 2012 Oct;33(20):2569-619 - PubMed
  23. JACC Cardiovasc Interv. 2012 Oct;5(10):1013-8 - PubMed
  24. Am Heart J. 2013 Oct;166(4):684-693.e1 - PubMed
  25. JACC Cardiovasc Interv. 2010 Jan;3(1):22-31 - PubMed
  26. JACC Cardiovasc Interv. 2013 Feb;6(2):115-25 - PubMed
  27. Catheter Cardiovasc Interv. 2011 Oct 1;78(4):540-8 - PubMed
  28. J Am Coll Cardiol. 2013 Jan 29;61(4):e78-140 - PubMed
  29. N Engl J Med. 2009 Jan 15;360(3):213-24 - PubMed
  30. Eur Heart J. 2012 Oct;33(20):2551-67 - PubMed
  31. Eur Heart J. 2014 Oct 1;35(37):2541-619 - PubMed
  32. N Engl J Med. 2012 Sep 13;367(11):991-1001 - PubMed
  33. EuroIntervention. 2015 Jul;11(3):280-5 - PubMed

Publication Types